Table 2.
Cost savings for PCV13 vs. PCV7 pediatric vaccination in normal and pandemic influenza seasons
| Influenza scenario | IPD | Hospitalized pneumonia | Non-Hospitalized pneumonia | Vaccination | Total |
|---|---|---|---|---|---|
| Normal season |
$ 235 M |
$ 509 M |
$ 96 M |
($ 367 M) |
$ 472 M |
| Pandemic similar to 2009–2010 H1N1 | $ 358 M | $ 812 M | $ 213 M | ($ 367 M) | $ 1.02 B |
IPD, Invasive pneumococcal disease; M, Million; B, Billion.